ReviewMicroRNA (Shariqah, United Arab Emirates)2026
An Insight into the Emerging Role of Extracellular Vesicle-derived Noncoding RNAs in Colorectal Cancer.
Review in MicroRNA (Shariqah, United Arab Emirates), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) ranks among the most frequent and lethal cancers globally, with early detection remaining a significant challenge because of asymptomatic early stages and limitations of current screening methods. This underscores the pressing need for new, non-invasive biomarkers for early CRC detection to enhance patient outcomes. Advancements in the molecular biology of cancer have highlighted the importance of non-coding RNAs (ncRNAs) in the genesis and progression of CRC. Exosomal non-coding RNAs (ncRNAs), microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs) have shown promise in this regard. These molecules, carried by small extracellular vesicles known as exosomes, are key players in cell communication and have been associated with the regulation of essential cancer pathways, including cell proliferation, metastasis, and drug resistance. This review discusses the potential of exosomal ncRNAs as innovative biomarkers and therapeutic targets in CRC. This study covers their role in cancer biology, the challenges in their application, and future directions for leveraging these ncRNAs to advance CRC diagnosis and treatment. Exploring exosomal ncRNAs opens new avenues for enhancing CRC management through early detection and targeted therapy, potentially transforming oncology patient care.
Indexed as
Identifiers
42703176What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.